Cartalax (20mg)

$69.97

Cartalax (also known as AED or AC-4) is a tripeptide complex (alanine-glutamic acid-aspartic acid) that modulates cartilage and bone metabolism by targeting cellular pathways in chondrocytes and thyroid C cells.

Category: Vials

Description
Reviews (0)

Cartalax Peptide Bioregulator Description

Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid. Its structure enables interaction with cellular mechanisms in cartilage (chondrocytes) and bone-regulating thyroid cells. The peptide may support joint health by promoting collagen production—a key structural protein in connective tissues—and reducing programmed cell death (apoptosis) in stressed cartilage cells. Its anti-inflammatory effects stem from inhibiting enzymes like matrix metalloproteinases that break down cartilage, while simultaneously curbing inflammatory signaling molecules. Cartalax also appears to influence calcium metabolism through thyroid C cells, potentially aiding bone density.

Peptide Information

Property	Value
Peptide Sequence	Ala-Glu-Asp
Molecular Formula	C12H19N3O8
Molecular Weight	333.29 g/mol
PubChem CID	87815447
Synonyms	Ala-Glu-Asp, alanyl-glutamyl-aspartic acid, T-31 peptide, H-Ala-Glu-Asp-OH

Cartalax Structure

Molecule

Source: PubChem

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.